{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:10:52Z","timestamp":1793812252252,"version":"4.6.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Carbapenem-resistant <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic> (CRE) infections are emerging as a crisis in developing countries. We aim to investigate the epidemiologic characteristics and antibiotic treatment strategies of CRE sepsis in very preterm infants (VPIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>This cross-sectional study included all infants born at 24\u201331 weeks of gestation or birth weight &lt;1500\u2009g who developed late-onset sepsis caused by <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>, as recorded in the 2022 Chinese Neonatal Network database. Late-onset sepsis was defined as sepsis occurring after 72 hours of birth.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 11,447 VPIs admitted, 205 infants had 207 episodes of <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>-related late-onset sepsis, of which 27 (13.0%) were caused by CRE. The most common CRE pathogens were <jats:italic toggle=\"yes\">Klebsiella<\/jats:italic> spp. (66.7%, 18\/27). Multivariate analysis identified prior carbapenem exposure as an independent risk factor for CRE sepsis (adjusted odds ratio: 2.33; 95% confidence interval: 1.02\u20135.49). In the CRE group, mortality due to <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic> sepsis (22.2% vs. 10.1%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.07) and all-cause mortality during hospitalization (29.6% vs. 13.5%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) were both higher than that in the non-CRE group. For empirical antibiotic therapy, of the 27 CRE cases, 21 (77.8%) were treated with meropenem alone and 6 (28.6%) of these infants died from CRE sepsis. For definitive therapy, 17\/22 (77.3%) received monotherapy, of which 12 (70.6%) were treated with meropenem, while 5 (22.7%) received combination therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In Chinese neonatal intensive care units, 13.0% of late-onset <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic> sepsis in VPIs was caused by CRE, which was associated with a significant mortality rate. Meropenem-based regimens remain the primary treatment for CRE sepsis, though with a high treatment failure rate.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004891","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:06:28Z","timestamp":1749139588000},"page":"e394-e399","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Late-onset Carbapenem-resistant Enterobacteriaceae Sepsis Among Very Preterm Infants: A Multicenter Study in China"],"prefix":"10.1097","volume":"44","author":[{"given":"Shujuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neonatology, Children\u2019s Hospital of Fudan University"},{"name":"NHC Key Laboratory of Neonatal Diseases, Fudan University, Children\u2019s Hospital of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Children\u2019s Hospital of Fudan University"},{"name":"NHC Key Laboratory of Neonatal Diseases, Fudan University, Children\u2019s Hospital of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Children\u2019s Hospital of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neonatology, People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoo K.","family":"Lee","sequence":"additional","affiliation":[{"name":"Maternal-Infant Care Research Center"},{"name":"Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Children\u2019s Hospital of Fudan University"},{"name":"NHC Key Laboratory of Neonatal Diseases, Fudan University, Children\u2019s Hospital of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Shi","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Children\u2019s Hospital of Fudan University"},{"name":"NHC Key Laboratory of Neonatal Diseases, Fudan University, Children\u2019s Hospital of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"R1-20251013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge.","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"R2-20251013","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"R3-20251013","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/antibiotics11081082","article-title":"Antimicrobial resistance and its spread is a global threat.","volume":"11","author":"Aljeldah","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R4-20251013","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3201\/eid2910.230153","article-title":"Carbapenem-resistant Klebsiella pneumoniae in large public acute-care healthcare system, New York, New York, USA, 2016-2022.","volume":"29","author":"Lee","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"R5-20251013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jgar.2024.02.004","article-title":"Clinical characteristics and risk factors for neonatal bloodstream infection due to carbapenem-resistant Enterobacteriaceae: a single-centre Chinese retrospective study.","volume":"37","author":"Fang","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"R6-20251013","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/antibiotics12020284","article-title":"Intestinal colonization of preterm neonates with carbapenem resistant enterobacteria at hospital discharge.","volume":"12","author":"Mijac","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R7-20251013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00431-014-2365-8","article-title":"Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.","volume":"174","author":"Tsiatsiou","year":"2015","journal-title":"Eur J Pediatr"},{"key":"R8-20251013","doi-asserted-by":"crossref","first-page":"fmaa057","DOI":"10.1093\/tropej\/fmaa057","article-title":"Carbapenem-resistant Klebsiella pneumoniae outbreak in a neonatal intensive care unit: risk factors for mortality.","volume":"67","author":"Bor","year":"2021","journal-title":"J Trop Pediatr"},{"key":"R9-20251013","first-page":"487","article-title":"Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit.","volume":"38","author":"Abrahams","year":"2023","journal-title":"S Afr J Infect Dis"},{"key":"R10-20251013","doi-asserted-by":"crossref","first-page":"106933","DOI":"10.1016\/j.ijantimicag.2023.106933","article-title":"Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.","volume":"62","author":"Meng","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"R11-20251013","doi-asserted-by":"crossref","first-page":"29486","DOI":"10.1038\/s41598-024-80974-2","article-title":"Clinical characteristics and mortality risk factors of premature infants with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"key":"R12-20251013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QCO.0000000000000371","article-title":"Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment.","volume":"30","author":"Folgori","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"R13-20251013","first-page":"ciae403","article-title":"Infectious diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections [published online ahead of print August 7, 2024].","author":"Tamma","journal-title":"Clin Infect Dis"},{"key":"R14-20251013","doi-asserted-by":"crossref","first-page":"e2118904","DOI":"10.1001\/jamanetworkopen.2021.18904","article-title":"Assessment of neonatal intensive care unit practices, morbidity, and mortality among very preterm infants in China.","volume":"4","author":"Cao","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R15-20251013","doi-asserted-by":"crossref","first-page":"711200","DOI":"10.3389\/fped.2021.711200","article-title":"Data quality improvement and internal data audit of the Chinese neonatal network data collection system.","volume":"9","author":"Sun","year":"2021","journal-title":"Front Pediatr"},{"key":"R16-20251013","article-title":"About Carbapenem-resistant Enterobacterales.","year":"2024"},{"key":"R17-20251013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2021.08.067","article-title":"Antibiotic use in neonatal intensive care units in China: a multicenter cohort study.","volume":"239","author":"Jiang","year":"2021","journal-title":"J Pediatr"},{"key":"R18-20251013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.","volume":"187","author":"Bell","year":"1978","journal-title":"Ann Surg"},{"key":"R19-20251013","first-page":"341","article-title":"Antimicrobial resistance profile of clinical strains isolated from children in China: report from the ISPED program in 2022.","volume":"18","author":"Fu","year":"2023","journal-title":"Chin J Evid Based Pediatr"},{"key":"R20-20251013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13756-020-0686-0","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.","volume":"9","author":"Zhu","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"R21-20251013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhin.2023.09.018","article-title":"Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.","volume":"142","author":"Bar Ilan","year":"2023","journal-title":"J Hosp Infect"},{"key":"R22-20251013","first-page":"223","article-title":"Clinical outcome of neonates with carbapenem-resistant Enterobacteriaceae infections at the King Edward VIII Hospital\u2019s neonatal unit, Durban, South Africa.","volume":"36","author":"Mzimela","year":"2021","journal-title":"S Afr J Infect Dis"},{"key":"R23-20251013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhin.2017.05.025","article-title":"Risk factors and clinical outcomes for carbapenem-resistant Gram-negative late-onset sepsis in a neonatal intensive care unit.","volume":"97","author":"Nour","year":"2017","journal-title":"J Hosp Infect"},{"key":"R24-20251013","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(24)00495-1","article-title":"Neonatal bacterial sepsis.","volume":"404","author":"Strunk","year":"2024","journal-title":"Lancet"},{"key":"R25-20251013","doi-asserted-by":"crossref","first-page":"e00342","DOI":"10.1128\/spectrum.00342-24","article-title":"No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.","volume":"12","author":"Ishii","year":"2024","journal-title":"Microbiol Spectr"},{"key":"R26-20251013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12866-023-03038-x","article-title":"Molecular characteristics and antimicrobial resistance profiles of carbapenem-resistant Klebsiella pneumoniae isolates at a tertiary hospital in Nanning, China.","volume":"23","author":"Wei","year":"2023","journal-title":"BMC Microbiol"},{"key":"R27-20251013","doi-asserted-by":"crossref","first-page":"106728","DOI":"10.1016\/j.micpath.2024.106728","article-title":"Molecular epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae infections during 2020-2021 in Northwest China.","volume":"106728","author":"Chen","year":"2024","journal-title":"Microb Pathog"},{"key":"R28-20251013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jhin.2018.05.005","article-title":"Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection\/colonization among neonates in China.","volume":"100","author":"Yin","year":"2018","journal-title":"J Hosp Infect"},{"key":"R29-20251013","first-page":"2850","article-title":"Expert consensus on the diagnosis, treatment, and prevention of carbapenem-resistant Enterobacteriaceae infections in China.","volume":"101","year":"2021","journal-title":"Nat Med J Chin"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:09:30Z","timestamp":1760375370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004891","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}